# OnCo record cpi-008 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cpi-008/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cpi-008" ;
  schema:name "CPI-008"@en ;
  schema:alternateName "cRGD-ZW800-1"@en, "cyclo(arginyl-glycyl-aspartyl-D-tyrosyl-lysyl)-nizaracianine-1"@en ;
  schema:description "CPI-008 (cRGD-ZW800-1) is an experimental dye that sticks to tumour tissue so surgeons can see it under near-infrared light. It has been tested in phase 2 trials and has European orphan status for head and neck cancer."@en ;
  schema:url <https://onco.cc/drugs/cpi-008/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05752149>, <https://clinicaltrials.gov/study/NCT04191460>, <https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3253>, <https://clinicaltrials.gov/study/NCT04191460>, <https://clinicaltrials.gov/study/NCT05518071> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Tumour-targeted near-infrared fluorescence imaging agent" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/fluorescence-guided-surgery/> ;
  onco:companies <https://onco.cc/companies/curadel-pharma/> .